United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - mometasone furoate - spray - 50microgram/1dose

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pilsco ltd - mometasone furoate - spray - 50microgram/1dose

Malta - English - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg/spray - nasal preparations

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

drogsan İlaçları sanayi ve ticaret a.Ş, turkey - mometasone furoate - nasal spray - 0.05 %

Malta - English - Medicines Authority

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg/spray - nasal preparations

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

schering-plough labo n.v. - mometasone (mometasone furoate) - spray nasal (suspension) - 50mcg/dose

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - mometasone furoate monohydrate eqv mometasone furoate - spray, suspension - mometasone furoate monohydrate eqv mometasone furoate 0.05% w/v

Canada - English - Health Canada

sanis health inc - mometasone furoate (mometasone furoate monohydrate) - spray, metered dose - 50mcg - mometasone furoate (mometasone furoate monohydrate) 50mcg - corticosteroids

Malta - English - Medicines Authority

n.v. organon kloosterstraat 6, nl-5349 ab oss, netherlands - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg - nasal preparations

Israel - English - Ministry of Health

novartis israel ltd - glycopyrronium as bromide; indacaterol as acetate; mometasone furoate - hard capsule - mometasone furoate 160 mcg; glycopyrronium as bromide 50 mcg; indacaterol as acetate 150 mcg - mometasone - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.important limitations of use:enerzair breezhaler is not indicated in patients with copd.